Clinical Trial Update: Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating acute oral doses of CBD and hippocampal response during an fMRI memory task; study currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cbd-related Conditions

Drugs mentioned

• CBD (cannabidiol)

Snippet

Sponsor: Hartford Hospital | Conditions: CBD | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING